Skip to main content
2026 CRT Conference Main banner

CRT 2026

Spotlight

Session:: CRT Predicts

CRT PREDICTS | ORBITA-CTO

Sunday, March 8, 2026
10:40 AM - 11:00 AM EST
Location: Spotlight Theater

    Moderator(s)

  • Gregg W. Stone, MD, FACC, MSCAI

    Physician
    Mount Sinai
    New York, New York, United States

    Disclosure(s): Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)

    • Panel Discussant(s)

  • Rhian E. Davies, DO MS

    Interventional Cardiology
    WellSpan York Hospital
    Annville, Pennsylvania, United States

    Disclosure(s): Terumo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Kathleen E. Kearney, MD

    Associate Professor
    University of Washington
    SEATTLE, Washington, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Fastwave: Stock Options [in privately held companies] (Ongoing); J&J Med Tech/Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novonordisk: Consulting Fees (e.g., advisory boards) (Terminated, February 1, 2026); Teleflex Inc, Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Stephane Rinfret, MD, SM

    Director of Complex Coronary Interventions
    Georgia Heart Institute
    Gainesville, Georgia, United States

    Disclosure information not submitted.

  • Gerald S. Werner, MD, PhD, FSCAI

    Senior Consultant CTO
    University Heart Center Frankfurt/Main
    Frankfurt am Main, Hessen, Germany

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Gregg W. Stone, MD, FACC, MSCAI: Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)
Rhian E. Davies, DO MS: Terumo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Kathleen E. Kearney, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Fastwave: Stock Options [in privately held companies] (Ongoing); J&J Med Tech/Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novonordisk: Consulting Fees (e.g., advisory boards) (Terminated, February 1, 2026); Teleflex Inc, Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Gerald S. Werner, MD, PhD, FSCAI: No financial relationships to disclose